-

AccurKardia joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

American Heart Association consortium advances development of evidence-based health tech solutions

NEW YORK--(BUSINESS WIRE)--AccurKardia, a software company that provides device-agnostic and automated ECG analytics, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

The Innovators’ Network is a consortium that connects entrepreneurs, providers, researchers and payers. Innovators’ Network members also have access to the Association’s digital guidelines, recommendations, and best-in-class science as they develop digital healthcare technologies. Members collaborate with the Center in different ways, including the building of models for clinical outcome studies, lowering the significant cost of developing those studies independently, helping connect the science to technology, and providing evidence that a digital platform improves healthcare outcomes – a key concern for providers and payers.

“The Center aims to advance the rapid, efficient, and effective development of healthcare technology,” said Robert A. Harrington, M.D., FAHA, past president of the American Heart Association (2019-2020), volunteer chair of the American Heart Association’s Health Tech Advisory Group for the Center and Arthur L. Bloomfield professor and chair department of medicine, Stanford University. “Joining the Innovators’ Network gives members the opportunity to leverage the consortium and work toward broadening and deepening their engagement in this arena.”

“The AccurKardia team is excited to join the Innovators’ Network,” said Juan C. Jiménez, CEO of AccurKardia.We are eager to engage with the other network members and the Center, as we pursue our goal of delivering ECG analytics solutions that improve patient outcomes.”

AccurKardia joins the Innovators’ Network bringing with them a device-agnostic, API-accessible automated ECG analytics platform for clinical and consumer-grade ECG devices, telehealth and remote patient monitoring companies.

About AccurKardia

AccurKardia is a digital-first and software-only healthcare company focused on ECG analytics enabling a world in which a combination of smart devices, actionable data and efficient clinical intervention improves medical outcomes and saves lives. AccurKardia provides clinical-grade, device-agnostic, API-accessible automated ECG analytics to clinical and consumer-grade ECG devices, as well as telehealth and remote patient monitoring companies.

For more information about AccurKardia, please visit: https://www.accurkardia.com/.

Contacts

MEDIA:
Kelly Ferraro, River North Communications
kelly@rivernorthagency.com
(646) 275-7040

AccurKardia


Release Versions

Contacts

MEDIA:
Kelly Ferraro, River North Communications
kelly@rivernorthagency.com
(646) 275-7040

More News From AccurKardia

AccurKardia’s AccurECG™ Analysis System Receives FDA 510(k) Clearance

NEW YORK--(BUSINESS WIRE)--AccurKardia, a medical technology company delivering clinical-grade ECG interpretation software, announced today that its flagship product, the AccurECG™ Analysis System (“AccurECG” or the “System”), has been granted FDA 510(k) clearance. AccurECG™ is a cloud-based, device-agnostic and fully automated electrocardiogram (ECG) interpretation software platform. The groundbreaking AccurECG™ software provides an array of benefits, such as beat-by-beat analysis, ventricular...

AccurKardia Announces Final Closing of $2.7 Million Series Seed Round

NEW YORK--(BUSINESS WIRE)--AccurKardia, Inc., a medical AI software company delivering clinical-grade ECG interpretation software, today announced the final closing and completion of its $2.7 million seed funding. Investors include the Popular Impact Fund, an early-stage investment vehicle from Popular Inc. (NYSE: BPOP), alongside other private investors. This funding milestone marks a significant step towards AccurKardia’s goal of improving patients’ outcomes and saving millions of lives regar...

AccurKardia and Mawi Announce Strategic Collaboration to Provide Automated ECG Analytics for the new Mawi Watch

NEW YORK & LONDON--(BUSINESS WIRE)--AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocardiogram (ECG) analytics, announced today it will collaborate with Mawi, a medtech provider of medical grade wearables in the cardiac space, to integrate its proprietary ECG analytics into Mawi’s new cardiac monitoring watch. This collaboration highlights AccurKardia’s commitment to enabling world-class cardiac-care through remote patient monitoring solutions. As...
Back to Newsroom